Oral immunotherapy for Immunoglobulin E-mediated cow's milk allergy in children: A systematic review and meta analysis
- PMID: 36169249
- PMCID: PMC9476891
- DOI: 10.1002/iid3.704
Oral immunotherapy for Immunoglobulin E-mediated cow's milk allergy in children: A systematic review and meta analysis
Abstract
Backgound: Cow's milk allergy (CMA) is the most common allergy in infants that decreases the quality of life of patients and their families. Standard treatment for CMA is the strict avoidance of milk; new treatment strategies such as oral immunotherapy (OIT) have been sought for patients with CMA. We aimed to assess the clinical efficacy and safety of OIT in the treatment of children with immunoglobulin E-mediated CMA (IMCMA).
Methods: We searched all randomized controlled trials in which OIT is used to treat children with IMCMA from five international electronic databases. We estimated a pooled risk ratio (RR) for each outcome using a Mantel-Haenzel fixed-effects model if statistical heterogeneity was low.
Results: Eleven studies were chosen for meta-analysis, including a total of 469 children (242 OITs, 227 controls). One hundred and seventy-six patients (72.7%) in the OIT were desensitized compared with 49 patients (21.6%) in the control group (RR: 7.35, 95% confidence interval (CI): 2.82-19.13, p < .0001). The desensitization effect of OIT was particularly significant in children over 3 years old (RR: 18.05, 95% CI: 6.48-50.26, p < .00001). Although adverse effects were common, they usually involved mild reactions, but epinephrine use was more common in the OIT group (RR: 7.69, 95% CI: 2.16-27.33, p < .002).
Conclusion: OIT can lead to desensitization in the majority of individuals with IMCMA, especially in patients over 3 years old. A major problem of OIT is the frequency of adverse events, although most are mild. OIT may be an alternative treatment in the future.
Keywords: children; cow's milk allergy; desensitization; meta-analysis; oral immunotherapy.
© 2022 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interests.
Figures





Similar articles
-
Safety and efficacy profile and immunological changes associated with oral immunotherapy for IgE-mediated cow's milk allergy in children: systematic review and meta-analysis.J Investig Allergol Clin Immunol. 2014;24(5):298-307. J Investig Allergol Clin Immunol. 2014. PMID: 25345300 Review.
-
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update - XIII - Oral immunotherapy for CMA - Systematic review.World Allergy Organ J. 2022 Sep 8;15(9):100682. doi: 10.1016/j.waojou.2022.100682. eCollection 2022 Sep. World Allergy Organ J. 2022. PMID: 36185550 Free PMC article.
-
Oral and sublingual immunotherapy for egg allergy.Cochrane Database Syst Rev. 2014 Nov 18;(11):CD010638. doi: 10.1002/14651858.CD010638.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 Apr 20;4:CD010638. doi: 10.1002/14651858.CD010638.pub3. PMID: 25405335 Updated. Review.
-
Early introduction oral immunotherapy for IgE-mediated cow's milk allergy: A follow-up study confirms this approach as safe and appealing to parents.Immun Inflamm Dis. 2021 Sep;9(3):918-922. doi: 10.1002/iid3.447. Epub 2021 May 18. Immun Inflamm Dis. 2021. PMID: 34002933 Free PMC article.
-
Changes in biomarkers during a six-month oral immunotherapy intervention for cow's milk allergy.Acta Paediatr. 2016 Nov;105(11):1349-1354. doi: 10.1111/apa.13550. Acta Paediatr. 2016. PMID: 27537244 Clinical Trial.
Cited by
-
Efficacy and safety of oral immunotherapy for peanut, cow's milk, and hen's egg allergy: A systematic review of randomized controlled trials.Clin Transl Allergy. 2023 Jul;13(7):e12268. doi: 10.1002/clt2.12268. Clin Transl Allergy. 2023. PMID: 37488726 Free PMC article. Review.
-
Molecular Mechanism and Clinical Effects of Probiotics in the Management of Cow's Milk Protein Allergy.Int J Mol Sci. 2023 Jun 6;24(12):9781. doi: 10.3390/ijms24129781. Int J Mol Sci. 2023. PMID: 37372929 Free PMC article. Review.
-
The Future of Food Allergy Management: Advancements in Therapies.Curr Allergy Asthma Rep. 2024 Apr;24(4):161-171. doi: 10.1007/s11882-024-01133-1. Epub 2024 Feb 23. Curr Allergy Asthma Rep. 2024. PMID: 38393624 Review.
-
Predictive modeling for cow's milk allergy remission by low-dose oral immunotherapy in young children.World Allergy Organ J. 2024 May 17;17(5):100910. doi: 10.1016/j.waojou.2024.100910. eCollection 2024 May. World Allergy Organ J. 2024. PMID: 38800497 Free PMC article.
References
-
- Halken S, Muraro A, de Silva D, et al. EAACI guideline: preventing the development of food allergy in infants and young children (2020 update). Pediatr Allergy Immunol. 2021;12:1‐16. - PubMed
-
- Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133:291‐307. - PubMed
-
- Bingol A, Uygun DFK, Akdemir M, et al. Clinical phenotypes of childhood food allergies based on immune mechanisms: a multicenter study. Allergy Asthma Proc. 2021;42(3):e86‐e95. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources